Andreas Gerber

3.9k total citations
112 papers, 2.9k citations indexed

About

Andreas Gerber is a scholar working on General Health Professions, Pharmacology and Molecular Medicine. According to data from OpenAlex, Andreas Gerber has authored 112 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in General Health Professions, 21 papers in Pharmacology and 15 papers in Molecular Medicine. Recurrent topics in Andreas Gerber's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Health and Medical Studies (15 papers) and Antibiotic Resistance in Bacteria (15 papers). Andreas Gerber is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Health and Medical Studies (15 papers) and Antibiotic Resistance in Bacteria (15 papers). Andreas Gerber collaborates with scholars based in Germany, Switzerland and United States. Andreas Gerber's co-authors include William A. Craig, Matthias Klusch, P Weidmann, David L. Cohn, Marcus Schmidt, Karl W. Lauterbach, Dominik E. Uehlinger, Markus Lüngen, Charalabos‐Markos Dintsios and A. Paul Vastola and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Endocrinology.

In The Last Decade

Andreas Gerber

104 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Gerber Germany 29 924 578 412 381 369 112 2.9k
Mark G. Weiner United States 34 359 0.4× 448 0.8× 980 2.4× 462 1.2× 536 1.5× 145 4.4k
Johan Decruyenaere Belgium 47 786 0.9× 446 0.8× 2.5k 6.1× 90 0.2× 222 0.6× 216 7.0k
Hung-Jen Tang Taiwan 29 319 0.3× 695 1.2× 805 2.0× 455 1.2× 258 0.7× 68 5.9k
R. Scott Evans United States 47 346 0.4× 118 0.2× 975 2.4× 501 1.3× 970 2.6× 127 8.8k
Jonathan Stokes United Kingdom 30 420 0.5× 956 1.7× 580 1.4× 349 0.9× 709 1.9× 76 4.5k
Altamiro Costa‐Pereira Portugal 38 307 0.3× 80 0.1× 820 2.0× 179 0.5× 379 1.0× 164 4.5k
Wim Goettsch Netherlands 34 230 0.2× 258 0.4× 713 1.7× 1.6k 4.2× 475 1.3× 146 4.6k
Marco Cascella Italy 29 326 0.4× 94 0.2× 256 0.6× 177 0.5× 267 0.7× 240 5.3k
Yang Han China 17 187 0.2× 66 0.1× 1.4k 3.3× 581 1.5× 503 1.4× 51 15.3k
Daniel C. Baumgart Germany 43 250 0.3× 92 0.2× 3.6k 8.8× 208 0.5× 426 1.2× 139 12.3k

Countries citing papers authored by Andreas Gerber

Since Specialization
Citations

This map shows the geographic impact of Andreas Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Gerber more than expected).

Fields of papers citing papers by Andreas Gerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Gerber. The network helps show where Andreas Gerber may publish in the future.

Co-authorship network of co-authors of Andreas Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Gerber. A scholar is included among the top collaborators of Andreas Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Gerber. Andreas Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kampik, Timotheus, Andreas Gerber, Johannes Hoffart, et al.. (2024). Large Process Models: A Vision for Business Process Management in the Age of Generative AI. KI - Künstliche Intelligenz. 39(2). 81–95. 9 indexed citations
2.
Manen, Jeannette G. van, et al.. (2012). Using the Analytic Hierarchy Process to Elicit Patient Preferences. Patient. 5(4). 225–237. 48 indexed citations
3.
Stock, Stephanie, Markus Lüngen, Andrea von Berg, et al.. (2012). Is prevention of atopic eczema with hydrolyzed formulas cost‐effective? A health economic evaluation from Germany. Pediatric Allergy and Immunology. 23(6). 597–604. 21 indexed citations
4.
Grossman, Zachi, Diego Van Esso, Stefano del Torso, et al.. (2010). PRIMARY CARE PEDIATRICIANS' PERCEPTIONS OF VACCINE REFUSAL IN EUROPE. The Pediatric Infectious Disease Journal. 30(3). 255–256. 21 indexed citations
5.
Danner, Martin, et al.. (2010). Wo steht die Kosten-Nutzen-Bewertung des IQWiG. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 53(6). 615–622. 7 indexed citations
6.
Schmidt, Harald, Andreas Gerber, & Stephanie Stock. (2009). What can we learn from German health incentive schemes?. BMJ. 339(sep24 2). b3504–b3504. 28 indexed citations
7.
Lauterbach, Karl W., et al.. (2008). Wie wirkt sich die Einführung des Qualitätsmanagements auf die Arbeitszufriedenheit und Arbeitsbelastung aus? Exemplarische Untersuchung in einer Klinik. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 103(4). 219–227. 1 indexed citations
8.
Rosta, Judith & Andreas Gerber. (2007). Excessive working hours and health complaints among hospital physicians: a study based on a national sample of hospital physicians in Germany. SHILAP Revista de lepidopterología. 11 indexed citations
9.
Lauterbach, Karl W., et al.. (2006). Auswirkungen der ersten und zweiten Stufe der Tabaksteuererhöhung. Social Science Open Access Repository (GESIS – Leibniz Institute for the Social Sciences). 11–23. 1 indexed citations
10.
Lüngen, Markus, et al.. (2006). Gesundheitsfonds oder/und steuerfinanziert – die Umgestaltung der Krankenversicherung. Econstor (Econstor). 59(16). 3–11. 1 indexed citations
11.
Lüngen, Markus, Andreas Gerber, Christian Krauth, et al.. (2006). Hochspezialisierte ambulante Versorgung in Krankenhäusern : eine empirische Abschätzung von Kosten, Erlösen und mögliche Strategien. Social Science Open Access Repository (GESIS – Leibniz Institute for the Social Sciences). 11–29.
12.
Gerber, Andreas & Karl W. Lauterbach. (2005). Evidence-based Medicine: Why do Opponents and Proponents use the same Arguments?. Health Care Analysis. 13(1). 59–71. 3 indexed citations
13.
Klusch, Matthias, Andreas Gerber, & Marcus Schmidt. (2005). Semantic Web Service Composition Planning with OWLS-Xplan ∗. National Conference on Artificial Intelligence. 55–62. 174 indexed citations
14.
Gerber, Andreas, Markus Lüngen, & Karl W. Lauterbach. (2005). Evidence-based medicine is rooted in Protestant exegesis. Medical Hypotheses. 64(5). 1034–1038. 3 indexed citations
15.
Lauterbach, Karl W., et al.. (2005). Kosteneffektivität der Prävention der koronaren Herzkrankheit in Deutschland. Zeitschrift für Kardiologie. 94(S3). iii100–iii104. 4 indexed citations
16.
Gerber, Andreas & Matthias Klusch. (2004). AGRICOLA - Agenten für mobile Planungsdienste in der Landwirtschaft.. Künstliche Intell.. 18. 38.
17.
Gerber, Andreas & Matthias Klusch. (2002). Intelligent Systems: Agent-Based Integrated Services for Timber Production and Sales.. IEEE Distributed Systems Online. 3. 1 indexed citations
18.
Gerber, Andreas, et al.. (2001). A Holonic Multi-Agent Coordination Server. The Florida AI Research Society. 200–204. 1 indexed citations
19.
Lew, Daniel P., Jorge Garbino, Andreas Gerber, & Philippe Sudre. (1996). Use of Antimicrobials in Swiss Hospitals. Drugs. 52(Supplement 2). 88–91. 7 indexed citations
20.
Gerber, Andreas, et al.. (1989). Once-daily versus thrice-daily administration of netilmicin in combination therapy ofPseudomonas aeruginosa infection in a man-adapted neutropenic animal model. European Journal of Clinical Microbiology & Infectious Diseases. 8(3). 233–237. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026